IXICO announced a strategic collaboration with Medidata to combine IXICO's neuroimaging analytics with Medidata's global clinical trial platform. Management (CEO Bram Goorden) said the partnership should accelerate IXICO's commercial reach in clinical trials and support revenue growth, a positive but not transformative development for the stock.
IXICO announced a strategic collaboration with Medidata to combine IXICO's neuroimaging analytics with Medidata's global clinical trial platform. Management (CEO Bram Goorden) said the partnership should accelerate IXICO's commercial reach in clinical trials and support revenue growth, a positive but not transformative development for the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.35
